Literature DB >> 12488063

Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity.

Vivian Mitropoulou1, Phillip D Harvey, Liza A Maldari, Patrick J Moriarty, Antonia S New, Jeremy M Silverman, Larry J Siever.   

Abstract

BACKGROUND: Individuals with schizotypal personality disorder (SPD) share cognitive deficits with schizophrenic patients, suggesting that these deficits represent a core feature of the schizophrenia spectrum. We investigated the neuropsychological profile in SPD patients compared with two comparison groups: healthy volunteers (HV) and patients who met criteria for another non-schizophrenia spectrum personality disorder (NSS).
METHODS: We tested 48 DSM-III-R SPD patients, 22 NSS and 32 HV on a neuropsychologic battery that included the California Verbal Learning Test (CVLT), Trail Making A and B, the DOT test of working memory, the Stroop Color-Word Interference, the Paced Auditory Serial Addition Test (PASAT), the Wechsler Memory Scale Visual Reproduction Test (WMSV-R), and the Wechsler Adult Intelligence Scale vocabulary and block design.
RESULTS: Normative standards for performance were created using the HV group. SPD patients performed significantly worse compared with HVs; specifically, SPD patients demonstrated impaired performance on the PASAT and the WMSV-R immediate and delayed recall compared to HV. Moreover, SPD patients were impaired in the PASAT and the WMSV-R immediate condition compared with the NSS group. The NSS patients did not differ from HV on any of the cognitive tasks. The interpersonal factor of the schizotypal symptoms inversely correlated with the PASAT score (r = -.32, p <.006).
CONCLUSIONS: Compared with HVs, SPD patients demonstrate modest cognitive impairment. These differences reached statistical significance for the PASAT (an auditory working memory task), and the WMSV-R immediate and delayed recall (a learning-recall test). In contrast, performance of NSS patients did not differ from that of HVs. The types of deficits observed in SPD patients are qualitatively similar to but milder than those seen in patients with schizophrenia.

Entities:  

Mesh:

Year:  2002        PMID: 12488063     DOI: 10.1016/s0006-3223(02)01426-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  21 in total

1.  Fronto-temporal disconnectivity in schizotypal personality disorder: a diffusion tensor imaging study.

Authors:  Motoaki Nakamura; Robert W McCarley; Marek Kubicki; Chandlee C Dickey; Margaret A Niznikiewicz; Martina M Voglmaier; Larry J Seidman; Stephan E Maier; Carl-Fredrik Westin; Ron Kikinis; Martha E Shenton
Journal:  Biol Psychiatry       Date:  2005-06-22       Impact factor: 13.382

2.  Spatial working memory as a cognitive endophenotype of schizophrenia: assessing risk for pathophysiological dysfunction.

Authors:  Alice M Saperstein; Rebecca L Fuller; Matthew T Avila; Helene Adami; Robert P McMahon; Gunvant K Thaker; James M Gold
Journal:  Schizophr Bull       Date:  2006-05-10       Impact factor: 9.306

3.  When does cognitive decline occur in the period prior to the first episode of schizophrenia?

Authors:  Philip D Harvey
Journal:  Psychiatry (Edgmont)       Date:  2009-07

4.  The genetics of cognitive impairment in schizophrenia.

Authors:  Philip D Harvey
Journal:  Psychiatry (Edgmont)       Date:  2008-06

5.  Factors in sensory processing of prosody in schizotypal personality disorder: an fMRI experiment.

Authors:  Chandlee C Dickey; Istvan A Morocz; Daniel Minney; Margaret A Niznikiewicz; Martina M Voglmaier; Lawrence P Panych; Usman Khan; Rayna Zacks; Douglas P Terry; Martha E Shenton; Robert W McCarley
Journal:  Schizophr Res       Date:  2010-04-01       Impact factor: 4.939

6.  Relationship between personality disorder dimensions and verbal memory functioning in a community population.

Authors:  Subin Park; Jin Pyo Hong; Hochang B Lee; Jack Samuels; O Joseph Bienvenu; Hye Yoon Chung; William W Eaton; Paul T Costa; Gerald Nestadt
Journal:  Psychiatry Res       Date:  2012-02-16       Impact factor: 3.222

7.  Alterations in white matter pathways in Angelman syndrome.

Authors:  Sarika U Peters; Walter E Kaufmann; Carlos A Bacino; Adam W Anderson; Pavani Adapa; Zili Chu; Ragini Yallampalli; Elfrides Traipe; Jill V Hunter; Elisabeth A Wilde
Journal:  Dev Med Child Neurol       Date:  2010-12-01       Impact factor: 5.449

8.  Neurocognition and conversion to psychosis in adolescents at high-risk.

Authors:  D J Walder; V Mittal; H D Trotman; A L McMillan; E F Walker
Journal:  Schizophr Res       Date:  2008-02-20       Impact factor: 4.939

9.  Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients.

Authors:  Erin A Hazlett; Monte S Buchsbaum; M Mehmet Haznedar; Randall Newmark; Kim E Goldstein; Yuliya Zelmanova; Cathryn F Glanton; Yuliya Torosjan; Antonia S New; Jennifer N Lo; Vivian Mitropoulou; Larry J Siever
Journal:  Schizophr Res       Date:  2008-02-13       Impact factor: 4.939

Review 10.  Pharmacological manipulation of human working memory.

Authors:  Deanna M Barch
Journal:  Psychopharmacology (Berl)       Date:  2004-01-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.